These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
224 related articles for article (PubMed ID: 36095024)
21. Whole-exome sequencing reveals germline-mutated small cell lung cancer subtype with favorable response to DNA repair-targeted therapies. Tlemsani C; Takahashi N; Pongor L; Rajapakse VN; Tyagi M; Wen X; Fasaye GA; Schmidt KT; Desai P; Kim C; Rajan A; Swift S; Sciuto L; Vilimas R; Webb S; Nichols S; Figg WD; Pommier Y; Calzone K; Steinberg SM; Wei JS; Guha U; Turner CE; Khan J; Thomas A Sci Transl Med; 2021 Jan; 13(578):. PubMed ID: 33504652 [TBL] [Abstract][Full Text] [Related]
22. Exome sequencing reveals frequent deleterious germline variants in cancer susceptibility genes in women with invasive breast cancer undergoing neoadjuvant chemotherapy. Ellingson MS; Hart SN; Kalari KR; Suman V; Schahl KA; Dockter TJ; Felten SJ; Sinnwell JP; Thompson KJ; Tang X; Vedell PT; Barman P; Sicotte H; Eckel-Passow JE; Northfelt DW; Gray RJ; McLaughlin SA; Moreno-Aspitia A; Ingle JN; Moyer AM; Visscher DW; Jones K; Conners A; McDonough M; Wieben ED; Wang L; Weinshilboum R; Boughey JC; Goetz MP Breast Cancer Res Treat; 2015 Sep; 153(2):435-43. PubMed ID: 26296701 [TBL] [Abstract][Full Text] [Related]
23. Germline mutations of renal cancer predisposition genes and clinical relevance in Chinese patients with sporadic, early-onset disease. Wu J; Wang H; Ricketts CJ; Yang Y; Merino MJ; Zhang H; Shi G; Gan H; Linehan WM; Zhu Y; Ye D Cancer; 2019 Apr; 125(7):1060-1069. PubMed ID: 30548481 [TBL] [Abstract][Full Text] [Related]
24. Rare germline variants in childhood cancer patients suspected of genetic predisposition to cancer. Sylvester DE; Chen Y; Grima N; Saletta F; Padhye B; Bennetts B; Wright D; Krivanek M; Graf N; Zhou L; Catchpoole D; Kirk J; Latchoumanin O; Qiao L; Ballinger M; Thomas D; Jamieson R; Dalla-Pozza L; Byrne JA Genes Chromosomes Cancer; 2022 Feb; 61(2):81-93. PubMed ID: 34687117 [TBL] [Abstract][Full Text] [Related]
26. Tumor sequencing is useful to refine the analysis of germline variants in unexplained high-risk breast cancer families. Van Marcke C; Helaers R; De Leener A; Merhi A; Schoonjans CA; Ambroise J; Galant C; Delrée P; Rothé F; Bar I; Khoury E; Brouillard P; Canon JL; Vuylsteke P; Machiels JP; Berlière M; Limaye N; Vikkula M; Duhoux FP Breast Cancer Res; 2020 Apr; 22(1):36. PubMed ID: 32295625 [TBL] [Abstract][Full Text] [Related]
27. Whole Exome Sequencing Identifies Novel Genetic Alterations in Patients with Pheochromocytoma/Paraganglioma. Seo SH; Kim JH; Kim MJ; Cho SI; Kim SJ; Kang H; Shin CS; Park SS; Lee KE; Seong MW Endocrinol Metab (Seoul); 2020 Dec; 35(4):909-917. PubMed ID: 33397043 [TBL] [Abstract][Full Text] [Related]
28. Rare MYC-N11S germline mutation indicative of inherited breast cancer in a multigeneration family. Budurlean L; Baker M; Broach J BMJ Case Rep; 2022 Nov; 15(11):. PubMed ID: 36368728 [TBL] [Abstract][Full Text] [Related]
29. Clinical and genomic features of Chinese lung cancer patients with germline mutations. Peng W; Li B; Li J; Chang L; Bai J; Yi Y; Chen R; Zhang Y; Chen C; Pu X; Jiang M; Li J; Zhong R; Xu F; Chen B; Xu L; Wang N; Huan J; Dai P; Guan Y; Yang L; Xia X; Yi X; Wang J; Yu F; Wu L Nat Commun; 2022 Mar; 13(1):1268. PubMed ID: 35273153 [TBL] [Abstract][Full Text] [Related]
30. Evaluation of pathogenetic mutations in breast cancer predisposition genes in population-based studies conducted among Chinese women. Zeng C; Guo X; Wen W; Shi J; Long J; Cai Q; Shu XO; Xiang Y; Zheng W Breast Cancer Res Treat; 2020 Jun; 181(2):465-473. PubMed ID: 32318955 [TBL] [Abstract][Full Text] [Related]
31. Whole-exome Sequencing Reveals New Potential Susceptibility Genes for Japanese Familial Pancreatic Cancer. Takai E; Nakamura H; Chiku S; Kubo E; Ohmoto A; Totoki Y; Shibata T; Higuchi R; Yamamoto M; Furuse J; Shimizu K; Takahashi H; Morizane C; Furukawa T; Yachida S Ann Surg; 2022 Apr; 275(4):e652-e658. PubMed ID: 32826389 [TBL] [Abstract][Full Text] [Related]
32. Determining the frequency of pathogenic germline variants from exome sequencing in patients with castrate-resistant prostate cancer. Hart SN; Ellingson MS; Schahl K; Vedell PT; Carlson RE; Sinnwell JP; Barman P; Sicotte H; Eckel-Passow JE; Wang L; Kalari KR; Qin R; Kruisselbrink TM; Jimenez RE; Bryce AH; Tan W; Weinshilboum R; Wang L; Kohli M BMJ Open; 2016 Apr; 6(4):e010332. PubMed ID: 27084275 [TBL] [Abstract][Full Text] [Related]
33. Intraductal/ductal histology and lymphovascular invasion are associated with germline DNA-repair gene mutations in prostate cancer. Isaacsson Velho P; Silberstein JL; Markowski MC; Luo J; Lotan TL; Isaacs WB; Antonarakis ES Prostate; 2018 Apr; 78(5):401-407. PubMed ID: 29368341 [TBL] [Abstract][Full Text] [Related]
35. Evaluation of the contribution of germline variants in BRCA1 and BRCA2 to uveal and cutaneous melanoma. Johansson PA; Nathan V; Bourke LM; Palmer JM; Zhang T; Symmons J; Howlie M; Patch AM; Read J; Holland EA; Schmid H; Warrier S; Glasson W; Höiom V; Wadt K; Jönsson G; Olsson H; Ingvar C; Mann G; Brown KM; Hayward NK; Pritchard AL Melanoma Res; 2019 Oct; 29(5):483-490. PubMed ID: 31464824 [TBL] [Abstract][Full Text] [Related]
36. The Fanconi anemia DNA damage repair pathway in the spotlight for germline predisposition to colorectal cancer. Esteban-Jurado C; Franch-Expósito S; Muñoz J; Ocaña T; Carballal S; López-Cerón M; Cuatrecasas M; Vila-Casadesús M; Lozano JJ; Serra E; Beltran S; Brea-Fernández A; Ruiz-Ponte C; Castells A; Bujanda L; Garre P; Caldés T; Cubiella J; Balaguer F; Castellví-Bel S Eur J Hum Genet; 2016 Oct; 24(10):1501-5. PubMed ID: 27165003 [TBL] [Abstract][Full Text] [Related]
37. Rare Germline Variants Are Associated with Rapid Biochemical Recurrence After Radical Prostate Cancer Treatment: A Pan Prostate Cancer Group Study. Burns D; Anokian E; Saunders EJ; Bristow RG; Fraser M; Reimand J; Schlomm T; Sauter G; Brors B; Korbel J; Weischenfeldt J; Waszak SM; Corcoran NM; Jung CH; Pope BJ; Hovens CM; Cancel-Tassin G; Cussenot O; Loda M; Sander C; Hayes VM; Dalsgaard Sorensen K; Lu YJ; Hamdy FC; Foster CS; Gnanapragasam V; Butler A; Lynch AG; Massie CE; ; Woodcock DJ; Cooper CS; Wedge DC; Brewer DS; Kote-Jarai Z; Eeles RA Eur Urol; 2022 Aug; 82(2):201-211. PubMed ID: 35659150 [TBL] [Abstract][Full Text] [Related]
38. Whole Exome Sequencing Identifies Candidate Genes Associated with Hereditary Predisposition to Uveal Melanoma. Abdel-Rahman MH; Sample KM; Pilarski R; Walsh T; Grosel T; Kinnamon D; Boru G; Massengill JB; Schoenfield L; Kelly B; Gordon D; Johansson P; DeBenedictis MJ; Singh A; Casadei S; Davidorf FH; White P; Stacey AW; Scarth J; Fewings E; Tischkowitz M; King MC; Hayward NK; Cebulla CM Ophthalmology; 2020 May; 127(5):668-678. PubMed ID: 32081490 [TBL] [Abstract][Full Text] [Related]
39. Prevalence and Spectrum of Predisposition Genes With Germline Mutations Among Chinese Patients With Bowel Cancer. Xie Z; Ke Y; Chen J; Li Z; Wang C; Chen Y; Ding H; Cheng L Front Genet; 2021; 12():755629. PubMed ID: 35154239 [No Abstract] [Full Text] [Related]
40. Germline mutations in PPFIBP2 are associated with lethal prostate cancer. Wu Y; Yu H; Zheng SL; Feng B; Kapron AL; Na R; Boyle JL; Shah S; Shi Z; Ewing CM; Wiley KE; Luo J; Walsh PC; Carter HB; Helfand BT; Cooney KA; Xu J; Isaacs WB Prostate; 2018 Dec; 78(16):1222-1228. PubMed ID: 30043417 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]